The number of teenagers who have experienced mania — a hallmark of bipolar disorder — is close to the number of adults estimated to have the mood disorder, suggesting that for many the condition begins during adolescence, according to a new study.
The number of teenagers who have experienced mania, a hallmark of bipolar disorder, is close to the number of adults estimated to have the mood disorder, suggesting that for many the condition begins during adolescence, according to a US study.
(REUTERS) – The number of teenagers who have experienced mania, a hallmark of bipolar disorder, is close to the number of adults estimated to have the mood disorder, suggesting that for many the condition begins during adolescence, according to a Unite…
NEW YORK (Reuters Health) – The number of teenagers who have experienced mania — a hallmark of bipolar disorder — is close to the number of adults estimated to have the mood disorder, suggesting that for many the condition begins during adolescence, …
Study to Evaluate Impact of the Genecept™ Assay on Patients Outcomes Incorporates New Web-based Data Collection Approach(PRWeb May 07, 2012)Read the full story at
Should grieving people be considered clinically depressed? Kay Jamison, who has written about struggling with bipolar disorder, weighed in on that knotty question today.
"IT IS painful for me to look at someone in the eye," said a patient diagnosed with Asperger's syndrome when asked to describe his social interaction with other people. "Asperger's Syndrome may be defined as a Pervasive Developme…
Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression (PREVAIL 1 an…
The Depression Bipolar Support Alliance, Pinyon Ridge Chapter, meets every Monday at 6:30 p.m. If you are living with depressio…
Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression .